Menu Search
Equities

Broncus Holding Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2216:HKG.HS

Broncus Holding Corp

Actions
  • Price (HKD)1.69
  • Today's Change-0.06 / -3.43%
  • Shares traded516.00k
  • 1 Year change+164.06%
  • Beta0.9186
Data delayed at least 15 minutes, as of Feb 06 2026 07:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Broncus Holding Corp is an investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

  • Revenue in HKD (TTM)47.49m
  • Net income in HKD-118.37m
  • Incorporated2012
  • Employees193.00
  • Location
    Broncus Holding CorpRoom 801, 8/F, Building 8No. 88 Jiangling Road, Xixing StreetBinjiang DistrictHANGZHOU ChinaCHN
  • Websitehttps://www.broncus.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.